Cargando…

Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection

Cell-to-cell communication by exosomes controls normal and pathogenic processes(1,2). Viruses can spread in exosomes and thereby avoid immune recognition(3). While biogenesis, binding, and uptake of exosomes are well-characterized(4,5), delivery of exosome cargo into the cytoplasm is poorly understo...

Descripción completa

Detalles Bibliográficos
Autores principales: Costafreda, Maria Isabel, Abbasi, Abdolrahim, Lu, Hsinyi, Kaplan, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483988/
https://www.ncbi.nlm.nih.gov/pubmed/32541946
http://dx.doi.org/10.1038/s41564-020-0740-y
_version_ 1783580969102475264
author Costafreda, Maria Isabel
Abbasi, Abdolrahim
Lu, Hsinyi
Kaplan, Gerardo
author_facet Costafreda, Maria Isabel
Abbasi, Abdolrahim
Lu, Hsinyi
Kaplan, Gerardo
author_sort Costafreda, Maria Isabel
collection PubMed
description Cell-to-cell communication by exosomes controls normal and pathogenic processes(1,2). Viruses can spread in exosomes and thereby avoid immune recognition(3). While biogenesis, binding, and uptake of exosomes are well-characterized(4,5), delivery of exosome cargo into the cytoplasm is poorly understood(3). We report that phosphatidylserine receptor HAVCR1(6,7) and cholesterol transporter NPC1(8) participate in cargo delivery from exosomes of hepatitis A virus (HAV)-infected cells (exo-HAV) by clathrin-mediated endocytosis. Using CRISPR/Cas9 knockouts we show that these two lipid receptors, which interact in the late endosome(9), are necessary for membrane fusion and delivery of RNA from exo-HAVs into the cytoplasm. The HAVCR1/NPC1 pathway, which Ebola virus exploits to infect cells(9), mediates HAV infection by exo-HAV indicating that viral infection by this exosome mimicry mechanism does not require an envelope glycoprotein. The luminal viral RNA but not endosomal uncoating of HAV particles (vpHAV) contained in the exosome is mainly responsible for exo-HAV infectivity as assessed by methylene blue-inactivation of non-encapsidated RNA. In contrast, infectivity of vpHAV is pH-independent and requires HAVCR1 or other yet unidentified receptor(s) but not NPC1. Our findings show that envelope glycoprotein-independent fusion mechanisms are shared by exosomes and viruses, and call for a reassessment of the role of envelope glycoproteins in infection.
format Online
Article
Text
id pubmed-7483988
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-74839882020-12-15 Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection Costafreda, Maria Isabel Abbasi, Abdolrahim Lu, Hsinyi Kaplan, Gerardo Nat Microbiol Article Cell-to-cell communication by exosomes controls normal and pathogenic processes(1,2). Viruses can spread in exosomes and thereby avoid immune recognition(3). While biogenesis, binding, and uptake of exosomes are well-characterized(4,5), delivery of exosome cargo into the cytoplasm is poorly understood(3). We report that phosphatidylserine receptor HAVCR1(6,7) and cholesterol transporter NPC1(8) participate in cargo delivery from exosomes of hepatitis A virus (HAV)-infected cells (exo-HAV) by clathrin-mediated endocytosis. Using CRISPR/Cas9 knockouts we show that these two lipid receptors, which interact in the late endosome(9), are necessary for membrane fusion and delivery of RNA from exo-HAVs into the cytoplasm. The HAVCR1/NPC1 pathway, which Ebola virus exploits to infect cells(9), mediates HAV infection by exo-HAV indicating that viral infection by this exosome mimicry mechanism does not require an envelope glycoprotein. The luminal viral RNA but not endosomal uncoating of HAV particles (vpHAV) contained in the exosome is mainly responsible for exo-HAV infectivity as assessed by methylene blue-inactivation of non-encapsidated RNA. In contrast, infectivity of vpHAV is pH-independent and requires HAVCR1 or other yet unidentified receptor(s) but not NPC1. Our findings show that envelope glycoprotein-independent fusion mechanisms are shared by exosomes and viruses, and call for a reassessment of the role of envelope glycoproteins in infection. 2020-06-15 2020-09 /pmc/articles/PMC7483988/ /pubmed/32541946 http://dx.doi.org/10.1038/s41564-020-0740-y Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Costafreda, Maria Isabel
Abbasi, Abdolrahim
Lu, Hsinyi
Kaplan, Gerardo
Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title_full Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title_fullStr Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title_full_unstemmed Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title_short Exosome mimicry by an HAVCR1/NPC1 pathway of endosomal fusion mediates hepatitis A virus infection
title_sort exosome mimicry by an havcr1/npc1 pathway of endosomal fusion mediates hepatitis a virus infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483988/
https://www.ncbi.nlm.nih.gov/pubmed/32541946
http://dx.doi.org/10.1038/s41564-020-0740-y
work_keys_str_mv AT costafredamariaisabel exosomemimicrybyanhavcr1npc1pathwayofendosomalfusionmediateshepatitisavirusinfection
AT abbasiabdolrahim exosomemimicrybyanhavcr1npc1pathwayofendosomalfusionmediateshepatitisavirusinfection
AT luhsinyi exosomemimicrybyanhavcr1npc1pathwayofendosomalfusionmediateshepatitisavirusinfection
AT kaplangerardo exosomemimicrybyanhavcr1npc1pathwayofendosomalfusionmediateshepatitisavirusinfection